Earnings NewsHealthcareRepros Therapeutics beats by $0.07Nov. 10, 2014 9:11 AM ETRoyalty Pharma plc (RPRX) StockBy: Gaurav Batavia, SA News Editor Repros Therapeutics (NASDAQ:RPRX): Q3 EPS of -$0.32 beats by $0.07. Press Release Recommended For YouMore Trending NewsSee More »About RPRX StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgRPRX--Royalty Pharma plcTrending AnalysisTrending News